cladribine has been researched along with Hemorrhagic Thrombocythemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertele', V; Garattini, S; Gerardi, C; Joppi, R | 1 |
| Azagury, M; Duboucher, C; Flandrin, G; Martelli, JM; Morcelet, M | 1 |
1 review(s) available for cladribine and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Letting post-marketing bridge the evidence gap: the case of orphan drugs.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate | 2016 |
1 other study(ies) available for cladribine and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia.
Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Humans; Hydroxyurea; Leukemia, Hairy Cell; Male; Thrombocythemia, Essential | 2003 |